Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability StudyJacques Bonneterre, Mia von Euler, Beat Thürlimann et al.|Journal of Clinical Oncology|2000Cited by 840
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter studyW. Eiermann, Semiglazov Vf, M. Lassus et al.|Annals of Oncology|2001Cited by 714
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, As First-Line Therapy in Patients With Metastatic Breast Cancer Previously Treated With Anthracycline ChemotherapyHenri Roché, Hervé Curé, Louise Yelle et al.|Journal of Clinical Oncology|2007Cited by 225
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.Matthew J. Ellis, William R. Miller, Andrew Coop et al.|PubMed|2003Cited by 202